Trial Information
Study on Thrombosis Therapy in German Cancer Patients
Inclusion Criteria:
- patient with cancer and acute deep vein thrombosis and/or pulmonary embolism
Exclusion Criteria:
- life expectancy less that 6 months
- age less that 18 years
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
treatment time on low molecular weight heparin
Outcome Time Frame:
1 year
Safety Issue:
No
Principal Investigator
Axel Matzdorff, Prof.Dr.
Investigator Role:
Principal Investigator
Investigator Affiliation:
Caritasklinikum Saarbrücken, St. Theresia
Authority:
Germany: Federal Institute for Drugs and Medical Devices
Study ID:
DE-Thrombose-NIS-2012
NCT ID:
NCT01559883
Start Date:
February 2012
Completion Date:
July 2013
Related Keywords:
- Cancer
- Deep Vein Thrombosis
- Pulmonary Embolism
- cancer
- thrombosis
- pulmonary embolism
- anticoagulation
- low molecular weight heparin
- Embolism
- Pulmonary Embolism
- Thrombosis
- Venous Thrombosis